Please provide your email address to receive an email when new articles are posted on . The device significantly improved quality of life and symptoms among women with urgency urinary incontinence ...

A device to help women with impaired detrusor contractility (IDC) urinate has been approved by the U.S. Food and Drug Administration. The InFlow Intraurethral Valve-Pump contains four components, each ...

The FDA has granted a de novo marketing request for the Revi System for tibial neuromodulation to treat urinary incontinence with or without urinary urgency, BlueWind Medical announced on Thursday.

Enhanced wearable builds on Revi’s strong clinical evidence, meaningful symptom relief, and exceptionally high patient satisfaction. BlueWind Medical, Ltd., a leader in implantable Tibial ...